1. Berman E, Wittes RE, Leyland-Jones B, Casper ES, Gralla RJ, Howard J, Williams L, Baratz R, Young CW (1983) Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer. Cancer Res 43: 6096–6101
2. Busch FW, deVos S, Flehmig B, Herrmann F, Sandler Ch, Vallbracht A (1987) Inhibition of in vitro hematopoiesis by hepatitis A virus. Exp Hematol 15: 978–982
3. Durie BGM, Dalton WS (1988) Reversal of drug-resistance in multiple myeloma with verapamil. Br J Haematol 68: 203–206
4. Fine RL, Koizumi S, Curt GA, Chabner BA (1987) Effect of calcium channel blockers on human CFU-GM with cytotoxic drugs. J Clin Oncol 5: 489–495
5. Greene RF, Collins JM, Jenkins JF, Speyer JL, Myers CE (1983) Plasma pharmacokinetics of adriamycin and adriamycinol: Implications for the design of in vitro experiments and treatment protocols. Cancer Res 43: 3417–3421